Scientists at the Paul Scherrer Institute PSI have, for the first time, demonstrated a technique that synchronizes ultrashort ...

Stanford researchers have developed a flexible material that can quickly change its surface texture and colors, offering ...

And now that the rest of the league is starting to take this team seriously, it might be time for the Spurs to take a long ...

An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important ...

Mr. Celebi's appointment comes as Egle enhances its clinical development focus on autoimmune diseases, where recent validation of the IL-2 mechanism has created a significant opportunity for ...

Kefir has the potential to affect the gastrointestinal and oral microbial ecosystem, but there is insufficient evidence to ...

Carbs have long been villainized by diet culture. But for anyone who trains regularly, skipping them might be what’s actually ...

CK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options. CK0804, an investigational allogeneic regulatory T cell ...

Challenges remain, like regulatory hurdles and funding, but our team's grit and your support as shareholders make me ...

As these systems evolve, I believe therapeutic ultrasound is poised to become medicine's next general-purpose platform.

Indianapolis-based Eli Lilly and Co. announced Wednesday it intends to acquire Ventyx Biosciences, a clinical-stage ...